Related Experiment Video
Updated: Aug 14, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Current status of pneumococcal polysaccharide immunization in patients with sickle cell disease or impaired splenic
Abstract:
It is now possible to prevent effectively the occurrence of overwhelming pneumococcal infection from the majority of pneumococcal organisms in patients with increased susceptibility to infection. Immunization of patients with sickle cell disease and patients with splenectomy results in a significant increase in antibody amounts which persist for long periods of time. Patients under 2 years of age and patients with Hodgkin's disease and splenectomy respond less well. Most "vaccine failures" which have been described, have been in immunosuppressed patients, or a result of infection with S. pneumoniae type 6A. Future directions in the development of a more effective vaccine for patients under 2 years of age and immunosuppressed patients will include research efforts to formulate a new immunogenic vaccine. Definitive recommendations regarding booster immunization must await more definitive studies, but current data suggests that booster immunization is not necessary for at least 5-6 years following primary immunization.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Smallpox
Poliomyelitis
Respiratory Syncytial Virus Disease

